Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and deserve attention.
Investors are constantly on the hunt for undervalued, under-followed and emerging stocks. With countless methods available to retail traders, the challenge often lies in sifting through the abundance of information to uncover new opportunities and understand why certain stocks should be of interest.
Here’s a look at the Benzinga Stock Whisper Index for the week of Sept. 6:
Oracle Corporation ORCL: The technology giant is seeing strong interest from Benzinga readers ahead of Monday's first-quarter financial results.
The company is expected to report earnings per share of $1.33, up from $1.19 in last year's first quarter, according to data from Benzinga Pro. The company has beaten earnings per share estimates from analysts in seven straight quarters and eight of the past 10 quarters overall.
Analysts estimate the company will report first-quarter revenue of $13.24 billion, up from $12.94 billion in last year's first quarter. The company has missed revenue estimates from analysts in four straight quarters and six of the past 10 quarters overall.
Oracle highlighted AI demand in the fourth quarter with more than 30 AI sales contracts valued at over $12.5 billion signed, including a large contract with OpenAI. Oracle also announced a partnership with Google Cloud at the time.
Oracle shares are up 2.3% over the last five days, as seen on the Benzinga Pro chart below. Oracle stock is up 38% year-to-date in 2024.
![](https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/06105358/Screenshot-162.png)
Novavax Inc NVAX: Shares of the vaccine company were up over 4% in the past five days with news that the FDA granted Emergency Use Authorization of the company's updated COVID-19 vaccine. The updated vaccine is included in the recommendations from the U.S. Centers for Disease Control and Prevention (CDC).
The vaccine is the only protein-based option available in the U.S. for people aged 12 and older for the prevention of COVID-19. The company could also be drawing interest from investors ahead of two company presentations next week. Novavax will present at H.C. Wainwright and Baird investor conferences on Monday, Sept. 9 and Tuesday, Sept. 10, respectively.
![](https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/06105414/Screenshot-163.png)
Wheeler Real Estate Investment Trust WHLR: Shares of the real estate investment trust surged over 500% on the week after the company announced a circuit court affirmed the dismissal of a class action lawsuit involving holders of Cedar Realty preferred stock. Wheeler acquired Cedar in August 2022 and the lawsuit alleged a breach of contract related to Cedar's former board of directors.
"With this matter behind us, both companies remain well-positioned to execute on their strategic plans," Cedar and Wheeler CEO Andrew Franklin said.
The company owns 77 grocery-anchored shopping centers in the Northeast, Mid-Atlantic and Southeast covering 14 states. With the lawsuit behind the company, investors could see a positive long-term outlook.
![](https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/06105430/Screenshot-164.png)
Equinix Inc EQIX: The data center company saw strong interest from investors on the week with shares up minimally. The company announced it issued $750 million in green bonds across two completed offerings. The green bonds are being used to help with sustainability initiatives for the company.
"Green bonds serve as a valuable means to secure funding and support significant initiatives that enhance the sustainability of our operations," Equinix SVP Corporate Finance and Sustainability Katrina Rymill said. "Over the last five years, our green bonds have funded 172 green building projects across 105 sites, 33 energy efficient projects and two Power Purchase Agreement projects."
The new green bonds could help the company continue to invest in new efforts to help support the company's 86 consecutive quarters of top-line revenue growth, which the company said is the longest streak of any S&P 500 company.
![](https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/06105452/Screenshot-165.png)
Tenon Medical Inc TNON: Investor interest in the medical device company grew during the week thanks to two items. The company announced a 1:8 reverse stock split on Sept. 4 that took effect on Sept. 6. Reverse stock splits often draw attention from retail investors as they reduce the float and shares outstanding of a company.
Tenon also announced a peer-reviewed publication of its Catamaran SI Joint Fusion System. The peer review showed evidence of fusion at the 12-month mark post-procedure, the company said.
![](https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/06105510/Screenshot-166.png)
Stay tuned for next week's report, and follow Benzinga Pro for all the latest headlines and top market-moving stories here.
Read the latest Stock Whisper Index reports here:
Read Next:
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.